References
1. Cohen EG, Shaha AR, Rinaldo A, Devaney KO, Ferlito A. 2004. Medullary
thyroid carcinoma. Acta Oto-Laryngologica 124 (5):544-557.
2. Blankenship DR, Chin E, Terris DJ. 2005. Contemporary management of
thyroid cancer. American Journal of Otolaryngology 26 (4):249-260.
3. Wells SA, Jr., Asa SL, Dralle H, Elisei R, Evans DB, Gagel RF, Lee N,
Machens A, Moley JF, Pacini F, Raue F, Frank-Raue K, Robinson B,
Rosenthal MS, Santoro M, Schlumberger M, Shah M, Waguespack SG. 2015.
Revised American Thyroid Association guidelines for the management of
medullary thyroid carcinoma. Thyroid : official journal of the American
Thyroid Association 25 (6):567-610.
4. Pacini F, Castagna MG, Cipri C, Schlumberger M. 2010. Medullary
thyroid carcinoma. Clinical oncology (Royal College of Radiologists
(Great Britain)) 22 (6):475-485.
5. Moley JF. 2010. Medullary thyroid carcinoma: management of lymph node
metastases. Journal of the National Comprehensive Cancer Network : JNCCN
8 (5):549-556.
6. Smit J. 2013. Treatment of advanced medullary thyroid cancer. Thyroid
Res 6 Suppl 1 (Suppl 1):S7-S7.
7. Schlumberger M, Bastholt L, Dralle H, Jarzab B, Pacini F, Smit JWA.
2012. 2012 European Thyroid Association Guidelines for Metastatic
Medullary Thyroid Cancer. European Thyroid Journal 1 (1):5-14.
8. van Heerden JA, Grant CS, Gharib H, Hay ID, Ilstrup DM. 1990.
Long-term course of patients with persistent hypercalcitoninemia after
apparent curative primary surgery for medullary thyroid carcinoma.
Annals of surgery 212 (4):395-400; discussion 400-391.
9. Jimenez JM, Casey SO, Citron M, Khan A. 1995. Calcified pulmonary
metastases from medullary carcinoma of the thyroid. Computerized medical
imaging and graphics : the official journal of the Computerized Medical
Imaging Society 19 (4):325-328.
10. Afshar K, Alalawi R, Boylen CT. 2007. Micronodular radiographic
pulmonary pattern in metastatic medullary thyroid carcinoma. Journal of
the National Medical Association 99 (5):575-577.
11. Russ G. 2016. Risk stratification of thyroid nodules on
ultrasonography with the French TI-RADS: description and reflections.
Ultrasonography 35 (1):25-38.
12. Salahuddin M, Cherian S, Patel RAJ, Estrada-Y-Martin R. 2018.
Etiology of miliary nodules. CHEST 154 (4):583A.
13. Khan D, Danjuma M, Saddique MU, Murshed KAH, Yassin MA. 2020.
Adenocarcinoma of the Lung Mimicking Miliary Tuberculosis. Case Reports
in Oncology 13 (1):139-144.
14. Manko AG, Shilo K, McCallister JW A Case Of Diffuse Miliary
Pulmonary Infiltrates In A 35 Year-Old Man. American Thoracic Society.
https://www.thoracic.org/professionals/clinical-resources/clinical-cases/08-14.php.
Accessed June 12, 2020
15. Kimmig L, Bueno J. 2017. Miliary Nodules: Not Always Tuberculosis.
Annals of the American Thoracic Society 14 (12):1858-1860.
16. Abe K, Adachi I, Miyakawa S, Tanaka M, Yamaguchi K, Tanaka N, Kameya
T, Shimosato Y. 1977. Production of calcitonin, adrenocorticotropic
hormone, and beta-melanocyte-stimulating hormone in tumors derived from
amine precursor uptake and decarboxylation cells. Cancer research 37
(11):4190-4194.
17. Trimboli P, Treglia G, Guidobaldi L, Romanelli F, Nigri G, Valabrega
S, Sadeghi R, Crescenzi A, Faquin WC, Bongiovanni M, Giovanella L. 2015.
Detection rate of FNA cytology in medullary thyroid carcinoma: a
meta-analysis. Clinical endocrinology 82 (2):280-285.
18. Papaparaskeva K, Nagel H, Droese M. 2000. Cytologic diagnosis of
medullary carcinoma of the thyroid gland. Diagnostic cytopathology 22
(6):351-358.
19. Bugalho MJ, Santos JR, Sobrinho L. 2005. Preoperative diagnosis of
medullary thyroid carcinoma: fine needle aspiration cytology as compared
with serum calcitonin measurement. Journal of surgical oncology 91
(1):56-60.
20. Trimboli P, Cremonini N, Ceriani L, Saggiorato E, Guidobaldi L,
Romanelli F, Ventura C, Laurenti O, Messuti I, Solaroli E, Madaio R,
Bongiovanni M, Orlandi F, Crescenzi A, Valabrega S, Giovanella L. 2014.
Calcitonin measurement in aspiration needle washout fluids has higher
sensitivity than cytology in detecting medullary thyroid cancer: a
retrospective multicentre study. Clinical endocrinology 80 (1):135-140.
21. Bhanot P, Yang J, Schnadig VJ, Logroño R. 2007. Role of FNA cytology
and immunochemistry in the diagnosis and management of medullary thyroid
carcinoma: report of six cases and review of the literature. Diagnostic
cytopathology 35 (5):285-292.
22. Wells SA, Haagensen DE, Linehan WM, Farrell RE, Dilley WG. 1978. The
detection of elevated plasma levels of carcinoembryonic antigen in
patients with suspected or established medullary thyroid carcinoma.
Cancer 42 (3 Suppl):1498-1503.
23. Kebebew E, Ituarte PH, Siperstein AE, Duh QY, Clark OH. 2000.
Medullary thyroid carcinoma: clinical characteristics, treatment,
prognostic factors, and a comparison of staging systems. Cancer 88
(5):1139-1148.
24. Modigliani E, Cohen R, Campos JM, Conte-Devolx B, Maes B, Boneu A,
Schlumberger M, Bigorgne JC, Dumontier P, Leclerc L, Corcuff B, Guilhem
I. 1998. Prognostic factors for survival and for biochemical cure in
medullary thyroid carcinoma: results in 899 patients. The GETC Study
Group. Groupe d’étude des tumeurs à calcitonine. Clinical endocrinology
48 (3):265-273.